Labiotech.eu

News and Trends 23 Mar 2020

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in Canada, which could replace the need for daily antiretroviral pills. The treatment — branded as Cabenuva and developed in collaboration with Janssen — was approved by Health Canada to suppress HIV in adults with stable […]

March 23, 2020 - 2 minutesmins - By Jonathan Smith

Interview 23 Mar 2020

Riding the Wave of Cambridge Entrepreneurship

The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as well known for its startup culture. Jason Mellad, CEO of StartCodon — a new accelerator based there — believes the area is a great place to set up a new biotech. “When I arrived in 2004, there were several people, […]

March 23, 2020 - 9 minutesmins - By Helen Albert

News and Trends 20 Mar 2020

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has jumped on the coronavirus vaccine bandwagon along with the Institut Pasteur and other international partners. The collaboration will be led by the Parisian Institut Pasteur, whose vaccine technology — in this case modifying a measles virus vector to carry coronavirus […]

March 20, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 19 Mar 2020

Labiotech.eu’s Coverage of the Covid-19 Coronavirus

Like many others, the biopharma industry has been shaken by the rapid rise of the coronavirus outbreak. But unlike any other industry, biopharma can solve the growing threat through science and innovation. Our journalists are working hard to deliver as much information as possible on the current crisis. If quality information and independent journalism also […]

March 19, 2020 - 13 minutesmins - By Joachim Eeckhout

News and Trends 18 Mar 2020

OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments

Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in the Series A funding included public grants from the Austrian Research Promotion Agency and the promotional bank of the Austrian federal government, the Austria Wirtschaftsservice Gesellschaft, along with […]

March 18, 2020 - 2 minutesmins - By Anita Chakraverty

News and Trends 17 Mar 2020

CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute

The German biotech CureVac — which is developing an mRNA vaccine against coronavirus — has been granted up to €80M by the European Commission, shortly after a dispute erupted over an alleged acquisition offer from the US. The money was awarded to help CureVac quickly scale up the production of its candidate Covid-19 vaccine. It […]

March 17, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Mar 2020

Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial

The French company Sensorion has been forced to delay a phase II trial in people with hearing loss due to slow patient recruitment amid the current coronavirus disease (Covid-19) pandemic. The clinical trial is designed to test Sensorion’s lead candidate drug in people with sudden sensorineural hearing loss, a rare disorder where the patient can […]

March 16, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Mar 2020

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

French researchers have found that the levels of certain immune cells in the blood of kidney transplant recipients may predict their future risk for transplant rejection. At present, kidney transplantation is the best treatment for people with end-stage renal disease but introducing a ‘foreign’ organ into someone’s body comes with the risk of rejection by […]

March 13, 2020 - 3 minutesmins - By Laura Cowen

Startup Scout 13 Mar 2020

This Startup Hits Hidden Proteins to Make Cancer Immunotherapies

With one foot in Belgium and another in the US, Orionis Biosciences combines US and European talent to develop cancer immunotherapies targeting difficult protein targets. Mission: To fight cancer with two technologies. The first is modifying immune proteins called cytokines to trigger the body to produce specific immune cells against a tumor. The second is […]

March 13, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 12 Mar 2020

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

An antibiotic-free vaginal tablet developed by the Swedish company Gedea Biotech has cured 82% of women of the common vaginal infection bacterial vaginosis in a 24-patient clinical trial. Bacterial vaginosis occurs when the normal vaginal microflora — characterized by a high proportion of bacteria from the genus Lactobacillus — become unbalanced with an overgrowth of […]

March 12, 2020 - 3 minutesmins - By Laura Cowen

Expert Advice 12 Mar 2020

Five Challenges For Life Science Marketers in 2020

Developing a new drug has an estimated cost of €583M to €2.4B. Much of this spending goes towards companies, such as vendors, CROs, and CDMOs, who generate value by commercializing and industrializing innovations to improve the ways researchers study organisms and viruses in the early stages of drug development. For those of us in sales […]

March 12, 2020 - 14 minutesmins - By Mark Livingstone

Expert Advice 11 Mar 2020

Why Women’s Health Can Be a Good Investment

Since the Hormone Replacement Therapy market was destroyed almost overnight in 2002 after side effects were reported by researchers, there has been a lot of caution about investing in companies with a focus on women’s health. Mary Kerr, CEO of KaNDy Therapeutics and NeRRe Therapeutics, knows this only too well, but has not let it […]

March 11, 2020 - 13 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

Riding the Wave of Cambridge Entrepreneurship

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

Labiotech.eu’s Coverage of the Covid-19 Coronavirus

OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments

CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute

Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

This Startup Hits Hidden Proteins to Make Cancer Immunotherapies

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

Five Challenges For Life Science Marketers in 2020

Why Women’s Health Can Be a Good Investment

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!